{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:47:28Z","timestamp":1760042848798},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1743-422x-7-323","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T14:15:32Z","timestamp":1290003332000},"source":"Crossref","is-referenced-by-count":13,"title":["Myotoxicity of telbivudine in pre-existing muscle damage"],"prefix":"10.1186","volume":"7","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"issue":"suppl 5","key":"1067_CR1","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1002\/hep.22885","volume":"49","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ: Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 2009,49(suppl 5):S185-95. 10.1002\/hep.22885","journal-title":"Hepatology"},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.clinthera.2007.12.032","volume":"29","author":"SJ Matthews","year":"2007","unstructured":"Matthews SJ: Telbivudine for the management of chronic hepatitis B virus infection. Clin Ther 2007, 29: 2635-53. 10.1016\/j.clinthera.2007.12.032","journal-title":"Clin Ther"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12325-009-0004-y","volume":"26","author":"K Nash","year":"2009","unstructured":"Nash K: Telbivudine in the treatment of chronic hepatitis B. Adv Ther 2009, 26: 155-69. 10.1007\/s12325-009-0004-y","journal-title":"Adv Ther"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.3748\/wjg.14.3549","volume":"14","author":"XS Zhang","year":"2008","unstructured":"Zhang XS, Jin R, Zhang SB, Tao ML: Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol 2008, 14: 3549-53. 10.3748\/wjg.14.3549","journal-title":"World J Gastroenterol"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1056\/NEJMoa066422","volume":"357","author":"CL Lai","year":"2007","unstructured":"Lai CL, Gane E, Liaw YF, Globe Study Group, et al.: Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 2007, 357: 2576-88. 10.1056\/NEJMoa066422","journal-title":"N Engl J Med"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","volume":"136","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Gane E, Leung N, GLOBE Study Group, et al.: 2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 2009, 136: 486-95. 10.1053\/j.gastro.2008.10.026","journal-title":"Gastroenterology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-7-323\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T16:08:54Z","timestamp":1548173334000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-323","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,17]]},"article-number":"323"}}